Objective To determine whether cognitive therapy is effective in preventing the worsening of
emerging psychotic symptoms experienced by help seeking young people deemed to be at …

Background: It is increasingly argued that mental health service users should be consulted to
determine the outcomes of treatment they prioritise, and the elements of treatment they find …

Background Antipsychotic drugs are usually the first line of treatment for schizophrenia;
however, many patients refuse or discontinue their pharmacological treatment. We aimed to …

Background Little evidence is available for head-to-head comparisons of psychosocial
interventions and pharmacological interventions in psychosis. We aimed to establish whether a …

Background Grandiose delusions are arguably the most neglected psychotic experience in
research. Objectives We aimed to discover from patients: whether grandiose delusions have …

It is acknowledged that people with a schizophrenia-spectrum diagnosis experience higher
levels of stigma compared to any other mental health diagnosis. As a consequence, their …

Background Although clozapine is the treatment of choice for treatment-refractory schizophrenia,
30–40% of patients have an insufficient response, and others are unable to tolerate it. …

Background Evidence for the effectiveness of treatments in early-onset psychosis is sparse.
Current guidance for the treatment of early-onset psychosis is mostly extrapolated from trials …

Internalised shame and self-esteem have both been proposed to play an integral role in the
relationship between stigma and its negative psychological sequelae in people who …

Cognitive behavioural therapy for psychosis (CBTp) is, at times, perceived as a technical
therapy that undervalues the importance of human relationships and the fundamental …